INVESTEC GROUP LIMITED (INVE-EQO)
Botswana Stock Exchange · Botswana · prices in BWP · close of 21 Oct 2026
Key indicators
| Last close | BWP 124.96 |
|---|---|
| 52-week range | 105.86 – 124.96 |
| Return, 1 month / 3 months | +0.0% / +4.9% |
| Return, 1 year / 3 years | +12.5% / – |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 100 |
| Volatility (1 year) | 9.9% |
| Worst drawdown (1 year) | -4.7% |
| Average daily value traded | 0.43M BWP |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Investec Group is a banking and asset management company based in South Africa and the United Kingdom. It offers private banking and wealth management to individuals, and corporate and investment banking services to businesses and institutions. Its clients include high net worth individuals, companies and institutional investors, served through offices in southern Africa and the United Kingdom. The group also provides specialist lending, treasury and advisory services, and manages investment funds for its customers.
On this site INVESTEC GROUP LIMITED appears as a stock on the Botswana Stock Exchange (Botswana), code INVE-EQO, with prices in Botswana pula (BWP). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
INVESTEC GROUP LIMITED (INVE-EQO) trades on the Botswana Stock Exchange in Botswana. It last closed at BWP 124.96 on 21 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 8 of 41 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.5% and over the last three months it rose 4.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Botswana Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 4.7% | ||
| From 52-week high | 0.0% | ||
| Momentum | 90 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 4.9% | ||
| 6-month return | 4.9% | ||
| 12-month return, skipping the last month | 12.5% | ||
| Stability (higher is calmer) | 33 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 9.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -4.7% | ||
| Liquidity | 51 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.43M BWP | ||
| Zero-volume days | 91.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.0% |
| 3 months | +4.9% |
| 6 months | +4.9% |
| 1 year | +12.5% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 124.96 / 119.39 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.01 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Botswana Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.